Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT04746235 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04746235
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2026-10-31
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.